Inmed Stock Future Price Prediction


USD 2.85  0.17  6.34%   

Inmed Pharmaceuticals stock price prediction is an act of determining the future value of Inmed Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Inmed Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Inmed Pharmaceuticals and does not consider all of the tangible or intangible factors available from Inmed Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Inmed Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Please see Inmed Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Inmed Pharmaceuticals based on different types of headlines from major news networks to social media. The Inmed stock price prediction module provides an analysis of price elasticity to changes in media outlook on Inmed Pharmaceuticals over a specific investment horizon.
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Using Inmed Pharmaceuticals hype-based prediction, you can estimate the value of Inmed Pharmaceuticals from the perspective of Inmed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.

Inmed Pharmaceuticals Hype to Price Pattern

Investor biases related to Inmed Pharmaceuticals' public news can be used to forecast risks associated with investment in Inmed. The trend in average sentiment can be used to explain how an investor holding Inmed can time the market purely based on public headlines and social activities around Inmed Pharmaceuticals. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Inmed Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Inmed Pharmaceuticals.
This module is based on analyzing investor sentiment around taking a position in Inmed Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Inmed Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Inmed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Inmed Pharmaceuticals after-hype prediction price

  $ 2.82  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inmed Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inmed Pharmaceuticals in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
2 Analysts
LowTarget PriceHigh
Estimates (3)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inmed Pharmaceuticals. Your research has to be compared to or analyzed against Inmed Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Inmed Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inmed Pharmaceuticals.

Inmed Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Inmed Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Inmed Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Inmed Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Inmed Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Inmed Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Inmed Pharmaceuticals' historical news coverage. Inmed Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.14 and 17.98, respectively. We have considered Inmed Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 2.85
After-hype Price
Inmed Pharmaceuticals is dangerous asset. Analysis and calculation of next after-hype price of Inmed Pharmaceuticals is based on 3 months time horizon.

Inmed Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Inmed Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inmed Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Inmed Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.16  15.04   0.03   0.47  4 Events / Month1 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Inmed Pharmaceuticals Hype Timeline

On the 26th of November Inmed Pharmaceuticals is traded for 2.85. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of 0.47. Inmed is estimated to decline in value after the next headline with the price expected to drop to 2.82. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next newsis expected to be -1.05% whereas the daily expected return is currently at -0.16%. The volatility of related hype on Inmed Pharmaceuticals is about 508.97% with expected price after next announcement by competition of 3.32. About 18.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Inmed Pharmaceuticals recorded a loss per share of 1.17. The entity had not issued any dividends in recent years. The firm had 25.00 - 1.00 split on the 7th of September 2022. Considering the 90-day investment horizon the next estimated press release will be in about 4 days.
Please see Inmed Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Inmed Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Inmed Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Inmed Pharmaceuticals' future price movements. Getting to know how Inmed Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Inmed Pharmaceuticals may potentially react to the hype associated with one of its peers.

Inmed Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Inmed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Inmed using various technical indicators. When you analyze Inmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Inmed Pharmaceuticals Predictive Indicators

The successful prediction of Inmed Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Inmed Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Inmed Pharmaceuticals based on analysis of Inmed Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Inmed Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Inmed Pharmaceuticals's related companies.

Story Coverage note for Inmed Pharmaceuticals

The number of cover stories for Inmed Pharmaceuticals depends on current market conditions and Inmed Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Inmed Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Inmed Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Inmed Pharmaceuticals Short Properties

Inmed Pharmaceuticals' future price predictability will typically decrease when Inmed Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Inmed Pharmaceuticals often depends not only on the future outlook of the potential Inmed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inmed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.46%
Short Percent Of Float1.49%
Float Shares781.65k
Shares Short Prior Month38.56k
Average Daily Volume Last 10 Day3.53M
Average Daily Volume In Three Month1.52M
Date Short Interest31st of October 2022
Please see Inmed Pharmaceuticals Basic Forecasting Models to cross-verify your projections. You can also try Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for analysis

When running Inmed Pharmaceuticals price analysis, check to measure Inmed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inmed Pharmaceuticals is operating at the current time. Most of Inmed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inmed Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inmed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inmed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Inmed Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inmed Pharmaceuticals. If investors know Inmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inmed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.1 M
Return On Assets
Return On Equity
The market value of Inmed Pharmaceuticals is measured differently than its book value, which is the value of Inmed that is recorded on the company's balance sheet. Investors also form their own opinion of Inmed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inmed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inmed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inmed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inmed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Inmed Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inmed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.